Quantitative determination of the hybrid Bcr-Abl RNA in patients with chronic myelogenous leukaemia under interferon therapy
✍ Scribed by Marie-Claire Malinge; Francois Xavier Mahon; Marie Hélène Delfau; Laurence Daheron; Alain Kitzis; François Guilhot; Joseph Tanzer; Bernard Grandchamp
- Book ID
- 114712916
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 601 KB
- Volume
- 82
- Category
- Article
- ISSN
- 0007-1048
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The expression of c-abl, c-sis, c-myc and N-ras oncogenes was examined in 2 lymphoblastoid cell lines, one with Ph1 (PB-1049) and the other without Ph1 (LN-1049), both established from a patient with chronic myelogenous leukemia (CML), and in a Ph1-positive cell line (PB-1049-T) derived from a tumor
## Abstract Data demonstrating the superiority of nilotinib over imatinib in the frontline treatment of chronic myeloid leukemia (CML) and ongoing studies with dasatinib and bosutinib are rapidly changing the treatment landscape for CML. In this review, the authors discuss currently available thera